| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/19/2000 | EP0971892A1 Novel pyridine derivatives and pharmaceutical compositions containing them |
| 01/19/2000 | EP0971891A1 Thrombin inhibitors |
| 01/19/2000 | EP0971887A1 Metalloproteinase inhibitors |
| 01/19/2000 | EP0971885A1 Process for preparing indane-like compounds |
| 01/19/2000 | EP0971743A1 Stabilized medicaments containing cysteinyl derivatives |
| 01/19/2000 | EP0971740A2 Fibronectin binding protein compositions, antibodies thereto, and methods of use |
| 01/19/2000 | EP0971730A2 Assay for ligands to tyrosine kinase receptors |
| 01/19/2000 | EP0971727A1 Production process for intravenous immune serum globulin and resultant product |
| 01/19/2000 | EP0971724A1 Expression of active human factor ix in mammary tissue of transgenic animals |
| 01/19/2000 | EP0971714A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia |
| 01/19/2000 | EP0971710A1 Use of chelerythrine and radiation for tumor therapy |
| 01/19/2000 | EP0971706A2 Vascular remodeling agent |
| 01/19/2000 | EP0971588A1 Novel cannabinoid receptor modulators |
| 01/19/2000 | EP0971587A1 Quinoline leukotriene antagonists |
| 01/19/2000 | EP0841950A4 Neuronal progenitor cells and uses thereof |
| 01/19/2000 | EP0772631A4 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
| 01/19/2000 | EP0728144B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
| 01/19/2000 | EP0726899B1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments |
| 01/19/2000 | EP0625989B1 Dna sequences encoding novel growth/differentiation factors |
| 01/19/2000 | CN1242007A Cycloalkyl, lactam lactone and related compounds as 'beta'-amyloid peptide release inhibitors |
| 01/19/2000 | CN1242001A Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/19/2000 | CN1241997A Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 01/19/2000 | CN1241408A Medicine with wild cottonrose hibiscus |
| 01/19/2000 | CN1241407A Wild cottonrose hibiscus bud |
| 01/19/2000 | CN1048492C Quinuclidine derivatives and its preparation |
| 01/19/2000 | CN1048490C Cyclic derivatives, pharmacecctical compositions containg the same derivatives and their use |
| 01/18/2000 | US6015938 Osteoprotegerin |
| 01/18/2000 | US6015926 Adding dialkylzinc to chiral additive, adding second additive to form chiral zinc complex, mixing with organometallic reagent, reacting with carbonyl compound to form desired alcohol |
| 01/18/2000 | US6015913 Heating cocoa beans to loosen shell without roasting nib, winnowing nibs from shells, screw pressing nibs to produce cocoa butter and partially defatted cocoa solids |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015900 N-aminoalkylfluorenecarboxamides |
| 01/18/2000 | US6015892 Nucleotide sequences for diagnosis and treatment of related disorders; antisense/anticarcinogenic/antitumor agents; antiinflammatory/antiproliferative agents |
| 01/18/2000 | US6015834 Administering chelate compound; antiischemic, antiepileptic, and wound healing agents; treating brain and nervous system disorders |
| 01/18/2000 | US6015831 Thiophene nitrone compounds |
| 01/18/2000 | US6015827 Benzoxazole-4-carboxamides and their use in inhibiting poly (adp-ribose) polymerase activity and improving cytotoxic effectiveness of cytotoxic drugs or radiotherapy |
| 01/18/2000 | US6015824 Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders |
| 01/18/2000 | US6015822 Antiulcer, antidiarrhea, and antiarrhythmia agents; cardiovascular and gastrointestinal disorders |
| 01/18/2000 | US6015819 Administering adrenergic blocking agent; reduction of orthostatic fall in blood pressure side effect; fda orange book listed patent for silodosin |
| 01/18/2000 | US6015818 Quinoline derivatives as bradykinin agonists |
| 01/18/2000 | US6015814 Quinazoline derivative |
| 01/18/2000 | US6015812 N-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity |
| 01/18/2000 | US6015807 Protein kinase C inhibitor |
| 01/18/2000 | US6015805 Potent antiprogestational activity and are useful in the treatment of fibroids, endometriosis, cervical ripening prior to delivery, hormone replacement therapy and in the control of fertility. |
| 01/18/2000 | US6015798 Mixture of omega-3 polyunsaturated fatty acids and arginine, cats and dogs |
| 01/18/2000 | US6015786 Method for increasing sex steroid levels using IGF or IGF/IGFBP-3 |
| 01/18/2000 | US6015712 Antisense modulation of FADD expression |
| 01/18/2000 | US6015695 Immunoglobulins devoid of light chains |
| 01/18/2000 | US6015659 Inducement of thermotolerance with benzoquinonoid ansamycins |
| 01/18/2000 | US6015578 Trapidil for use in the therapy of syndrome that may be influenced by immunomodulators |
| 01/18/2000 | US6015558 Treatment of insulin resistance in obesity linked type II diabetes using antagonists to TNF-α function |
| 01/18/2000 | US6015556 Cytotoxic drug therapy |
| 01/18/2000 | CA2172472C Pyrido[3,2-e]pyrazinones with anti-asthmatic action and processes for their manufacture |
| 01/18/2000 | CA2136818C Sulfur-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism |
| 01/18/2000 | CA2001124C Treatment of hypertension |
| 01/18/2000 | CA2001123C Treatment of osteoporosis |
| 01/13/2000 | WO2000002051A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000002050A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000001835A2 Targeted integration into chromosomes using retroviral vectors |
| 01/13/2000 | WO2000001818A1 Human emr1-like g protein coupled receptor |
| 01/13/2000 | WO2000001817A2 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods |
| 01/13/2000 | WO2000001811A1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 01/13/2000 | WO2000001805A1 Cells and animals deficient in protein kinase c epsilon |
| 01/13/2000 | WO2000001726A1 Compounds with growth hormone releasing properties |
| 01/13/2000 | WO2000001706A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace) |
| 01/13/2000 | WO2000001704A2 Benzimidazoles, production thereof and use thereof as medicaments |
| 01/13/2000 | WO2000001702A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001701A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001699A1 Novel indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
| 01/13/2000 | WO2000001695A1 New benzoxazoles with pde-inhibiting activity |
| 01/13/2000 | WO2000001694A1 Paroxetine methanesulfonate |
| 01/13/2000 | WO2000001689A1 Process for producing (8- chloro-3,10- dibromo-6,11- dihydro- 5h-benzo [5,6]cyclohepta [1,2-b]pyridin-11-yl)- 1-piperidine |
| 01/13/2000 | WO2000001687A1 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/13/2000 | WO2000001676A1 Potassium channel blocking agents |
| 01/13/2000 | WO2000001671A2 Antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 01/13/2000 | WO2000001670A1 Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof |
| 01/13/2000 | WO2000001668A2 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 01/13/2000 | WO2000001666A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 01/13/2000 | WO2000001418A1 Transgene expression in polarized cells |
| 01/13/2000 | WO2000001414A1 Use of texaphyrins in macrophage-mediated disease |
| 01/13/2000 | WO2000001411A1 Farnesyl protein transferase inhibitors with in vivo radiosensitizing properties |
| 01/13/2000 | WO2000001410A1 Methods of inhibiting proliferative diseases by inhibiting tgf-beta mediated angiogenesis |
| 01/13/2000 | WO2000001409A2 Porcine circovirus and parvovirus vaccine |
| 01/13/2000 | WO2000001406A1 Medicinal utilization of heparin cofactor ii |
| 01/13/2000 | WO2000001404A1 Compositions and methods for $i(in vitro) fertilization |
| 01/13/2000 | WO2000001399A1 Companion animal therapeutic treat |
| 01/13/2000 | WO2000001389A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/13/2000 | WO2000001386A1 Farnesyl protein transferase inhibitors for treating arthropathies |
| 01/13/2000 | WO2000001383A1 Angiogenesis inhibitors |
| 01/13/2000 | WO2000001382A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001381A1 Substituted oxygen alicyclic compounds, including methods for synthesis thereof |
| 01/13/2000 | WO2000001380A1 cyclo-oxygenase inhibitor |
| 01/13/2000 | WO2000001378A1 Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection |
| 01/13/2000 | WO2000001375A2 Calcium channel blockers |
| 01/13/2000 | WO2000001349A2 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same |
| 01/13/2000 | WO1999060125A3 Secreted proteins |
| 01/13/2000 | WO1999059628A3 Combination therapy for the treatment of tumors |
| 01/13/2000 | WO1999059617A3 Immunoregulator |
| 01/13/2000 | WO1999057241A3 Myelin basic protein peptides and uses thereof |
| 01/13/2000 | WO1999050252A3 Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same |
| 01/13/2000 | WO1999046367A8 Methods of diagnosis and triage using cell activation measures |